Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Failed Dissolution Specifications
| Recalling firm | Supernus Pharmaceuticals, Inc. |
|---|---|
| Reason | Failed Dissolution Specifications |
| Risk class | Class III (Class III · low) |
| Status | Ongoing |
| Report date | Jul 29, 2026 |
| Initiated | Jul 6, 2026 |
| Region | MD, United States |
| Distribution | US Nationwide. |
| Quantity | 15,853 bottles |
| Code/Lot | Lot # 2075801, Exp Date: 31-Oct-2029. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0758-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0758-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.